Global Markets React to AstraZeneca Earnings, Swedish Economic Rebound, and Stalled Norwegian Retail Sales
Key Takeaways AstraZeneca (AZN) reported strong Q2 2025 earnings, surpassing revenue estimates with $14.46 billion and meeting core EPS expectations […]
